PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Business Contracts

Form of Performance-Based Restricted Stock Unit Award Agreement under the Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan, as amended (Filed With SEC on February 28, 2023)

Underwriting Agreement, dated as of January 24, 2023 by and among Pacific Biosciences of California, Inc. and Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, and Cowen and... (Filed With SEC on January 27, 2023)

Amended and Restated Development and Commercialization Agreement by and between the Registrant and Invitae Corporation dated June 24, 2022 (Filed With SEC on August 8, 2022)

Agreement and Plan of Merger and Plan of Reorganization among Pacific Biosciences of California, Inc., Apollo Merger Sub, Inc., Apollo Acquisition Sub, LLC, Omniome, Inc. and... (Filed With SEC on July 20, 2021)

Exclusive License Agreement by and between the Registrant and Cornell Research Foundation, Inc., dated as of February 1, 2004 (Filed With SEC on February 26, 2021)

Description of Registrants securities registered under Section 12 of the Exchange Act (Filed With SEC on February 28, 2020)

Form of Global Restricted Stock Unit Agreement under the Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan, as amended (Filed With SEC on May 26, 2022)

Form of Global Stock Option Agreement under the Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan, as amended (Filed With SEC on May 26, 2022)

Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan, as amended (Filed With SEC on May 26, 2022)

Change in Control and Severance Agreement, by and between the Registrant and Denis Zaccarin, Ph.D. effective November 4, 2020 (Filed With SEC on May 6, 2022)

Pacific Biosciences of California, Inc. 2020 Inducement Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on November 19, 2021)

Omniome Equity Incentive Plan of Pacific Biosciences of California, Inc. and related forms of agreement thereunder (Filed With SEC on November 5, 2021)

Omniome Equity Incentive Plan of Pacific Biosciences of California, Inc. and related forms of agreement thereunder (Filed With SEC on September 20, 2021)

Amendment to Development and Commercialization Agreement, dated as of June 3, 2021, by and between Pacific Biosciences of California, Inc. and Invitae Corporation (Filed With SEC on August 6, 2021)

Letter Relating to Employment Terms by and between the Registrant and Michele Farmer effective May 17, 2021 (Filed With SEC on August 6, 2021)

Registration Rights Agreement, dated as of July 19, 2021, by and between Pacific Biosciences of California, Inc. and each of the Investors (Filed With SEC on July 20, 2021)

Securities Purchase Agreement, dated as of July 19, 2021, by and between Pacific Biosciences of California, Inc. and each of the Investors (Filed With SEC on July 20, 2021)

Pacific Biosciences of California, Inc. 2020 Inducement Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on April 19, 2021)

Development and Commercialization Agreement by and between the Registrant and Invitae Corporation dated January 12, 2021 (Filed With SEC on February 26, 2021)

Letter Relating to Employment Terms by and between the Registrant and Mark Van Oene effective January 8, 2021 (Filed With SEC on February 26, 2021)

Amended Change in Control and Severance Agreement by and between the Registrant and Christian O. Henry dated February 3, 2021 (Filed With SEC on February 26, 2021)

Change in Control and Severance Agreement by and between the Registrant and Christian O. Henry effective September 14, 2020 (Filed With SEC on February 26, 2021)

Letter Relating to Employment Terms by and between the Registrant and Christian O. Henry effective September 14, 2020 (Filed With SEC on February 26, 2021)

Form of Change in Control and Severance Agreement for executive officers (Filed With SEC on February 26, 2021)

Letter Relating to Employment Terms by and between the Registrant and Peter Fromen effective January 8, 2021 (Filed With SEC on February 26, 2021)

Indenture, dated February 16, 2021, between Pacific Biosciences of California, Inc. and U.S. Bank National Association, as Trustee (Filed With SEC on February 17, 2021)

Form of Indenture related to 1.50% Convertible Senior Notes due 2028 (Filed With SEC on February 10, 2021)

Investment Agreement, dated as of February 9, 2021, between Pacific Biosciences of California, Inc. and SB Northstar LP (Filed With SEC on February 10, 2021)

2020 Inducement Equity Incentive Plan and forms of agreement thereunder (Filed With SEC on December 4, 2020)

Underwriting Agreement, dated as of November 10, 2020 by and among Pacific Biosciences of California, Inc., Morgan Stanley & Co. LLC and Cowen and Company, LLC, and the Selling... (Filed With SEC on November 13, 2020)

Change in Control and Severance Agreement by and between the Company and Susan G. Kim effective as of September 28, 2020 (Filed With SEC on November 3, 2020)

Letter Relating to Employment Terms Susan G. Kim effective as of September 28, 2020 (Filed With SEC on November 3, 2020)

Underwriting Agreement, dated as of August 11, 2020 by and among Pacific Biosciences of California, Inc., Morgan Stanley & Co. LLC and Cowen and Company, LLC (Filed With SEC on August 14, 2020)

Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan and related forms of agreement (Filed With SEC on August 5, 2020)

Agreement by and among Pacific Biosciences of California, Inc., Illumina, Inc. and FC Ops Corp., dated January 2, 2020 (Filed With SEC on January 2, 2020)

Amendment No. 1 to Agreement and Plan of Merger dated as of November 1, 2018 (Filed With SEC on September 26, 2019)

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (36)